Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Nucleoside Antimetabolite/Analog
    (2)
  • Drug Metabolite
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

sapacitabine

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
Sapacitabine
CS682, CYC682
TQ0245151823-14-2
Sapacitabine (CS682) is an orally available nucleoside analog precursor compound with potential anti-tumor activity for the study of acute myeloid leukemia.
  • Inquiry Price
7-10 days
Size
QTY
CNDAC hydrochloride
T13621134665-72-8
CNDAC hydrochloride, a nucleoside analog, is a metabolite of the sapacitabine.
  • Inquiry Price
Size
QTY
CNDAC
T13621L135598-68-4
CNDAC, a nucleoside analog, is a major metabolite of oral drug sapacitabine.
  • Inquiry Price
8-10 weeks
Size
QTY
RKS-262
T715491041469-97-9
RKS262 is a specific cyclin CDK inhibitor. RKS262 was identified by structural optimization of Nifurtimox which is currently undergoing phase II clinical trials to treat high-risk neuroblastoma. In a NCI(60) cell-line assay RKS262 exhibited significant cytotoxicity in ovarian cancer cells and a variety of other cell lines exceeding effects of commercial drugs such as cisplatin, 5-FU, cyclophosphamide or sapacitabine. Various leukemia cell-lines were most sensitive (GI(50): ~ 10 nM) while several non-small cell lung cancer cell lines and few cell lines from other tissues were relatively resistant (GI(50) > 1 µM) to RKS262 treatment.
  • Inquiry Price
6-8 weeks
Size
QTY